The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-12-0815
Issue:2010: 103/6 (June) pp. 1109–1281
Pages:1268-1269

The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood

L. J. Schober (1), A. L. Khandoga (1), S. M. Penz (1), W. Siess (1)

(1) Institute for Prevention of Cardiovascular Diseases, Ludwigs-Maximilians-Universität, München, Germany

DOI

http://dx.doi.org/10.1160/TH09-12-0815

Articles

You've 169 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...